1. Home
  2. TSLX vs PGEN Comparison

TSLX vs PGEN Comparison

Compare TSLX & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sixth Street Specialty Lending Inc.

TSLX

Sixth Street Specialty Lending Inc.

HOLD

Current Price

$19.23

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$4.93

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSLX
PGEN
Founded
2010
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
TSLX
PGEN
Price
$19.23
$4.93
Analyst Decision
Buy
Buy
Analyst Count
10
5
Target Price
$23.50
$7.67
AVG Volume (30 Days)
745.1K
3.4M
Earning Date
02-12-2026
03-18-2026
Dividend Yield
10.66%
N/A
EPS Growth
N/A
N/A
EPS
1.81
N/A
Revenue
$449,055,000.00
$6,309,000.00
Revenue This Year
N/A
$342.78
Revenue Next Year
N/A
$478.46
P/E Ratio
$10.62
N/A
Revenue Growth
N/A
59.20
52 Week Low
$18.58
$1.11
52 Week High
$25.17
$5.23

Technical Indicators

Market Signals
Indicator
TSLX
PGEN
Relative Strength Index (RSI) 25.63 58.55
Support Level $19.63 $4.41
Resistance Level $20.35 $5.00
Average True Range (ATR) 0.59 0.38
MACD -0.21 0.02
Stochastic Oscillator 3.85 90.00

Price Performance

Historical Comparison
TSLX
PGEN

About TSLX Sixth Street Specialty Lending Inc.

Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. It partners with companies across a variety of industries and excel at providing creative solutions to companies with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Share on Social Networks: